Clinical trial
Auxora for the Treatment of AKI and Modulation of Injurious "Crosstalk" With the Lung: A Randomized Control Trial (KOURAGE)
NCT06374797 is registered in ClinicalTrials.gov with CalciMedica, Inc. as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Auxora for the Treatment of AKI and Modulation of Injurious "Crosstalk" With the Lung: A Randomized Control Trial (KOURAGE)
- Lead sponsor
- CalciMedica, Inc.
- Phase
- Phase 2
- Overall status
- Terminated
- Start date
- July 1, 2024
- Completion date
- April 6, 2026
- Enrollment
- 122 (actual)
- Sites
- 33
Conditions
As the registry lists them; a condition with its own page is linked.